These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 18289787)

  • 1. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
    Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
    Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.
    Greco SJ; Sarkar S; Casadesus G; Zhu X; Smith MA; Ashford JW; Johnston JM; Tezapsidis N
    Neurosci Lett; 2009 May; 455(3):191-4. PubMed ID: 19429119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.
    Alvarez AR; Godoy JA; Mullendorff K; Olivares GH; Bronfman M; Inestrosa NC
    Exp Cell Res; 2004 Jul; 297(1):186-96. PubMed ID: 15194435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
    Chen X; Huang T; Zhang J; Song J; Chen L; Zhu Y
    Brain Res; 2008 Mar; 1200():99-106. PubMed ID: 18289510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
    Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
    J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.
    Alvarez G; Muñoz-Montaño JR; Satrústegui J; Avila J; Bogónez E; Díaz-Nido J
    Bipolar Disord; 2002 Jun; 4(3):153-65. PubMed ID: 12180271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
    J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
    Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
    Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.
    Caccamo A; Oddo S; Tran LX; LaFerla FM
    Am J Pathol; 2007 May; 170(5):1669-75. PubMed ID: 17456772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3β activity in rat primary cortical neurons.
    Kwon KJ; Lee EJ; Cho KS; Cho DH; Shin CY; Han SH
    Food Funct; 2015 Jun; 6(6):2058-67. PubMed ID: 26032477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
    Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
    J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease.
    Mendes CT; Mury FB; de Sá Moreira E; Alberto FL; Forlenza OV; Dias-Neto E; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2009 Feb; 259(1):16-22. PubMed ID: 18932008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium, a potential protective drug in Alzheimer's disease.
    Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J
    Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.